E-LIB Suche - Ergebnisse für: De Wachter, E

1

ECFS standards of care on CFTR-related disorders: Towards a..:

De Wachter, E ; De Boeck, K ; Sermet-Gaudelus, I...
Journal of Cystic Fibrosis. 23 (2024) 3 - p. 388-397 , 2024

Link: https://doi.org/10.1016/..

2

Letter to the editor: Risk of false newborn screening after..:

De Wachter, E ; Davies, JC ; Simmonds, NJ...
Journal of Cystic Fibrosis. 23 (2024) 1 - p. 176-177 , 2024

Link: https://doi.org/10.1016/..

3

ECFS standards of care on CFTR-related disorders: Identific..:

Simmonds, N.J. ; Southern, K.W. ; De Wachter, E....
Journal of Cystic Fibrosis. , 2024

Link: https://doi.org/10.1016/..

4

P390 Ageing with cystic fibrosis: challenges for patients a..:

Braun, S. ; Eyns, H. ; Vincken, S...
Journal of Cystic Fibrosis. 22 (2023) - p. S183 , 2023

Link: https://doi.org/10.1016/..

5

EPS6.05 A phase 3b study of the effects of elexacaftor/teza..:

Van Braeckel, E. ; De Wachter, E. ; Mall, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S53-S54 , 2023

Link: https://doi.org/10.1016/..

6

P136 ECFS syllabuses for the multidisciplinary team and wid..:

Smith, C. ; Chadwick, H.K ; Farinha, C....
Journal of Cystic Fibrosis. 22 (2023) - p. S106 , 2023

Link: https://doi.org/10.1016/..

7

P142 Review of diagnostic labels for patients with unconfir..:

Wanyama, S. Situma ; Daneau, G. ; De Wachter, E..
Journal of Cystic Fibrosis. 22 (2023) - p. S108 , 2023

Link: https://doi.org/10.1016/..

8

Ex vivo adult stem cell characterization from multiple musc..:

Corvelyn, M. ; Meirlevede, J. ; Deschrevel, J....
Differentiation. 133 (2023) - p. 25-39 , 2023

Link: https://doi.org/10.1016/..

9

WS09.02 Theratyping molecular defects of CFTR rare variants..:

Soeffers, Y. ; Cuyx, S. ; Proesmans, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S18 , 2023

Link: https://doi.org/10.1016/..

10

P001 Cystic fibrosis newborn screening (CF-NBS) start-up in..:

Proesmans, M. ; Regal, L. ; Eyskens, F....
Journal of Cystic Fibrosis. 21 (2022) - p. S61 , 2022

Link: https://doi.org/10.1016/..

11

185 Long-term safety and efficacy of elexacaftor/tezacaftor..:

Chmiel, J. ; Barry, P.J. ; Colombo, C....
Journal of Cystic Fibrosis. 21 (2022) - p. S108-S109 , 2022

Link: https://doi.org/10.1016/..

12

692 Importance of cystic fibrosis transmembrane conductance..:

Ramalho, A. ; Cuyx, S. ; Boon, M....
Journal of Cystic Fibrosis. 21 (2022) - p. S378 , 2022

Link: https://doi.org/10.1016/..

13

Everything in excess is opposed to nature, even vitamin D: ..:

Nauwynck, E ; Vanbesien, J ; De Schepper, J...
Endocrinology, Diabetes & Metabolism Case Reports. 2022 (2022) - p. , 2022

Link: https://doi.org/10.1530/..

14

P243 Psychosocial impact of 6 months of treatment with Symk..:

Braun, S. ; Eyns, H. ; Verbanck, S....
Journal of Cystic Fibrosis. 21 (2022) - p. S134-S135 , 2022

Link: https://doi.org/10.1016/..

15

ECFS standards of care on CFTR-related disorders: Updated d..:

Castellani, C ; De Boeck, K ; De Wachter, E...
Journal of Cystic Fibrosis. 21 (2022) 6 - p. 908-921 , 2022

Link: https://doi.org/10.1016/..